Sotera Health Company
Sotera Health Company
Your view on SHC
Overview
What the company does, where it operates, and who runs it.
About Sotera Health Company
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Michael B. Petras Jr.
- Headquarters
- 9100 South Hills Boulevard, Broadview Heights, OH, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Michael B. Petras Jr.
- Headquarters
- 9100 South Hills Boulevard, Broadview Heights, OH, US
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally.
The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries.
It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020.
Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Sotera Health Company, and the rating behind it. SHC last traded at $18.37, 32.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Sotera Health Company. Starting points for Sotera Health Company: P/E 32.0, EPS $0.57, beta 1.78 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Sotera Health Company. Sotera Health Company does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Sotera Health Company. Trailing twelve-month EPS for Sotera Health Company stands at $0.57. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Sotera Health Company. Sotera Health Company has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Sotera Health Company valued side by side against its closest peers. Sotera Health Company is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Sotera Health Company, and how their positions are changing. At a $5.24B market value, institutional positions materially move Sotera Health Company's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Sotera Health Company executives and directors. Shares of Sotera Health Company have traded between $9.53 and $17.78 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Sotera Health Company. Sotera Health Company is a $5.24B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Sotera Health Company. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Sotera Health Company. Coverage tracks Sotera Health Company within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.